Clinical Trials Logo

Clinical Trial Summary

This cross-sectional study was conducted, including those subjects tested for 1,25(OH)2D during Jan 2015-Dec 2021. Estimated glomerular filtration rate (eGFR) was calculated and subjects were classified into chronic kidney disease (CKD) stages. Associations between biochemical marker, calcium, phosphorus, magnesium, alkaline phosphatase, 1,25(OH)2D and CKD stages was determined.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05399251
Study type Observational [Patient Registry]
Source Aga Khan University Hospital, Pakistan
Contact
Status Completed
Phase
Start date January 1, 2015
Completion date December 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04564924 - To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI
Recruiting NCT04714918 - Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Recruiting NCT06288451 - DePTH: De-emphasize PTH Phase 2
Completed NCT04750460 - Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). Phase 3
Recruiting NCT05439980 - Improving Phosphate Control in Children With CKD
Recruiting NCT05096195 - PRevEnting FracturEs in REnal Disease 1 Phase 4
Recruiting NCT05242055 - Integrated Diagnosis and Treatment of CKD on Outcomes
Recruiting NCT04522622 - Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease Phase 4
Recruiting NCT05720273 - Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients Phase 4